Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00635934 · ClinicalTrials.gov registry record · NA
A-MAV™ Anterior Motion Segment Replacement
A NA study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT00635934: Completed NA study, sponsored by Medtronic Spinal and Biologics.
NCT00635934 is a NA study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00635934, a NA study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to collect safety and effectiveness data concerning the A-MAV™ Anterior Motion Segment Replacement device as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1. Overall success will be the primary clinical endpoint.
Interventions
- DEVICE A-MAV™ disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2005-12 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT00635934 record still lists
NCT00635934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which A-MAV™ disc is the first listed.
NCT00635934 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00635934 about?
NCT00635934 is a clinical study titled "A-MAV™ Anterior Motion Segment Replacement". The purpose of this clinical trial is to collect safety and effectiveness data concerning the A-MAV™ Anterior Motion Segment Replacement device as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1. Overall success will be the primary clinical endpoint.
What is the current status of trial NCT00635934?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2005-12. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00635934?
The interventions under investigation include: A-MAV™ disc (DEVICE).
Who is sponsoring clinical trial NCT00635934?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00635934's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia